Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.28363561 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.00778303 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.00778303 |
4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.15231389 |
5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.07191112 |
6 | negative regulation of cell killing (GO:0031342) | 4.88847185 |
7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.88847185 |
8 | positive thymic T cell selection (GO:0045059) | 4.85301180 |
9 | interferon-gamma production (GO:0032609) | 4.82872794 |
10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.81934011 |
11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.67756650 |
12 | leukocyte aggregation (GO:0070486) | 4.53228578 |
13 | response to interleukin-15 (GO:0070672) | 4.50951019 |
14 | T cell migration (GO:0072678) | 4.41555873 |
15 | * negative T cell selection (GO:0043383) | 4.37059868 |
16 | positive T cell selection (GO:0043368) | 4.33259515 |
17 | * negative thymic T cell selection (GO:0045060) | 4.14451718 |
18 | ribosomal small subunit assembly (GO:0000028) | 4.11716550 |
19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.03301170 |
20 | tolerance induction (GO:0002507) | 3.92049970 |
21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.86969323 |
22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.86115819 |
23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.86115819 |
24 | modulation by symbiont of host immune response (GO:0052553) | 3.86115819 |
25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.86115819 |
26 | modulation by symbiont of host defense response (GO:0052031) | 3.86115819 |
27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.86115819 |
28 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.84152064 |
29 | immunoglobulin mediated immune response (GO:0016064) | 3.80489870 |
30 | cellular response to interleukin-15 (GO:0071350) | 3.78997719 |
31 | positive regulation of B cell differentiation (GO:0045579) | 3.78578537 |
32 | * thymic T cell selection (GO:0045061) | 3.70271931 |
33 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.69254084 |
34 | * T cell selection (GO:0045058) | 3.61399362 |
35 | T cell receptor signaling pathway (GO:0050852) | 3.59159260 |
36 | T cell homeostasis (GO:0043029) | 3.56640880 |
37 | negative regulation of phagocytosis (GO:0050765) | 3.55445001 |
38 | viral transcription (GO:0019083) | 3.54415763 |
39 | regulation of B cell differentiation (GO:0045577) | 3.53887046 |
40 | response to peptidoglycan (GO:0032494) | 3.53131660 |
41 | regulation of granulocyte differentiation (GO:0030852) | 3.53106512 |
42 | response to muramyl dipeptide (GO:0032495) | 3.51598481 |
43 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.48450864 |
44 | mast cell activation (GO:0045576) | 3.47919347 |
45 | positive regulation of isotype switching (GO:0045830) | 3.45380192 |
46 | detection of bacterium (GO:0016045) | 3.45133514 |
47 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.41800377 |
48 | translational termination (GO:0006415) | 3.39304140 |
49 | detection of other organism (GO:0098543) | 3.36436677 |
50 | neutrophil activation involved in immune response (GO:0002283) | 3.34894092 |
51 | activated T cell proliferation (GO:0050798) | 3.29571946 |
52 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.28964850 |
53 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.28006159 |
54 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.28006159 |
55 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.25576490 |
56 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.24090801 |
57 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.23819711 |
58 | * T cell costimulation (GO:0031295) | 3.22670875 |
59 | definitive hemopoiesis (GO:0060216) | 3.18955073 |
60 | * lymphocyte costimulation (GO:0031294) | 3.18548009 |
61 | B cell mediated immunity (GO:0019724) | 3.16801923 |
62 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.16239167 |
63 | megakaryocyte development (GO:0035855) | 3.16001847 |
64 | positive regulation of granulocyte differentiation (GO:0030854) | 3.14093612 |
65 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.12173875 |
66 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.10130286 |
67 | positive regulation of interleukin-2 production (GO:0032743) | 3.09661870 |
68 | mast cell degranulation (GO:0043303) | 3.09461772 |
69 | mast cell activation involved in immune response (GO:0002279) | 3.09461772 |
70 | leukocyte degranulation (GO:0043299) | 3.09216901 |
71 | natural killer cell activation (GO:0030101) | 3.09107696 |
72 | regulation of mast cell degranulation (GO:0043304) | 3.07086612 |
73 | leukocyte cell-cell adhesion (GO:0007159) | 3.01723295 |
74 | B cell homeostasis (GO:0001782) | 3.00797223 |
75 | B cell receptor signaling pathway (GO:0050853) | 3.00541968 |
76 | DNA unwinding involved in DNA replication (GO:0006268) | 2.98851052 |
77 | myeloid cell activation involved in immune response (GO:0002275) | 2.98372914 |
78 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98147808 |
79 | lymphocyte homeostasis (GO:0002260) | 2.97561511 |
80 | translational elongation (GO:0006414) | 2.96834768 |
81 | positive regulation of B cell activation (GO:0050871) | 2.93217372 |
82 | regulation of regulatory T cell differentiation (GO:0045589) | 2.91887795 |
83 | macrophage activation involved in immune response (GO:0002281) | 2.91163534 |
84 | germinal center formation (GO:0002467) | 2.90410126 |
85 | regulation of mast cell activation (GO:0033003) | 2.90206541 |
86 | positive regulation of DNA recombination (GO:0045911) | 2.89070309 |
87 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.88539364 |
88 | T cell differentiation (GO:0030217) | 2.88181329 |
89 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.87935943 |
90 | regulation of erythrocyte differentiation (GO:0045646) | 2.87678741 |
91 | respiratory burst (GO:0045730) | 2.87359495 |
92 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.86367136 |
93 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.86280704 |
94 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.86280704 |
95 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.86087218 |
96 | regulation of isotype switching (GO:0045191) | 2.85917073 |
97 | positive regulation of B cell mediated immunity (GO:0002714) | 2.85699833 |
98 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.85699833 |
99 | defense response to protozoan (GO:0042832) | 2.85238470 |
100 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.83725979 |
101 | response to host immune response (GO:0052572) | 2.83725979 |
102 | myeloid dendritic cell activation (GO:0001773) | 2.83643299 |
103 | * negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.83483780 |
104 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.81848647 |
105 | response to type I interferon (GO:0034340) | 2.79973799 |
106 | positive regulation of mast cell activation (GO:0033005) | 2.79351831 |
107 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.78335342 |
108 | hepatocyte apoptotic process (GO:0097284) | 2.77411046 |
109 | type I interferon signaling pathway (GO:0060337) | 2.76239156 |
110 | cellular response to type I interferon (GO:0071357) | 2.76239156 |
111 | alpha-beta T cell activation (GO:0046631) | 2.76059213 |
112 | T cell proliferation (GO:0042098) | 2.75490249 |
113 | regulation of alpha-beta T cell activation (GO:0046634) | 2.75335874 |
114 | ribosomal small subunit biogenesis (GO:0042274) | 2.74911316 |
115 | protein targeting to ER (GO:0045047) | 2.74765155 |
116 | regulation of response to interferon-gamma (GO:0060330) | 2.74594205 |
117 | cotranslational protein targeting to membrane (GO:0006613) | 2.74085679 |
118 | negative regulation of interleukin-12 production (GO:0032695) | 2.73499846 |
119 | neutrophil activation (GO:0042119) | 2.73352482 |
120 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.72560351 |
121 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.72203323 |
122 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.71522295 |
123 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.70701181 |
124 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.70056432 |
125 | regulation of B cell apoptotic process (GO:0002902) | 2.70052328 |
126 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.69812259 |
127 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.69768498 |
128 | cellular extravasation (GO:0045123) | 2.69168621 |
129 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.68699895 |
130 | NIK/NF-kappaB signaling (GO:0038061) | 2.68684661 |
131 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.68643501 |
132 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.68230799 |
133 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.67406525 |
134 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.67266807 |
135 | regulation of B cell mediated immunity (GO:0002712) | 2.66051874 |
136 | leukocyte homeostasis (GO:0001776) | 2.65673637 |
137 | natural killer cell differentiation (GO:0001779) | 2.65059017 |
138 | T cell activation (GO:0042110) | 2.64855394 |
139 | Peyers patch development (GO:0048541) | 2.64124101 |
140 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.64124101 |
141 | viral life cycle (GO:0019058) | 2.63048571 |
142 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.62618314 |
143 | protein localization to kinetochore (GO:0034501) | 2.62156814 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.21140244 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.54739622 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.21636614 |
4 | MYC_22102868_ChIP-Seq_BL_Human | 3.54228409 |
5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.10939491 |
6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.08774485 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.96527512 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.92410076 |
9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.88204682 |
10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.78702712 |
11 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.68389706 |
12 | * MYB_26560356_Chip-Seq_TH2_Human | 2.61874828 |
13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.57659434 |
14 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.51784096 |
15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.50692284 |
16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.49774547 |
17 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.46630395 |
18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.46160782 |
19 | MAF_26560356_Chip-Seq_TH1_Human | 2.44071306 |
20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.42775052 |
21 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.39164314 |
22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.38069882 |
23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.37794482 |
24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.33328929 |
25 | * MYB_26560356_Chip-Seq_TH1_Human | 2.30112706 |
26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.27533974 |
27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.25401657 |
28 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.21928288 |
29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.14999879 |
30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.14740713 |
31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.06205993 |
32 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.04878278 |
33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04522399 |
34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.00791196 |
35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97842943 |
36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.97360712 |
37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.95338619 |
38 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.86649039 |
39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83088811 |
40 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83008675 |
41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78692838 |
42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.78511859 |
43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78190790 |
44 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.77016746 |
45 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.73162003 |
46 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.72732990 |
47 | * MAF_26560356_Chip-Seq_TH2_Human | 1.69099377 |
48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.68384120 |
49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66858820 |
50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.63352182 |
51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.62891454 |
52 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.52562502 |
53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50634004 |
54 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.49587805 |
55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48885584 |
56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48730683 |
57 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.48568984 |
58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.47716507 |
59 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45933283 |
60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.43596164 |
61 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.41953355 |
62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39365086 |
63 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.37600818 |
64 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.35239424 |
65 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32240914 |
66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31732073 |
67 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.31686756 |
68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31148127 |
69 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30654214 |
70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30642042 |
71 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28268772 |
72 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.28018578 |
73 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.24266003 |
74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22906752 |
75 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22634650 |
76 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.20527673 |
77 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.20090945 |
78 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.18637361 |
79 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12675675 |
80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11569405 |
81 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.09184730 |
82 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08988350 |
83 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.08496208 |
84 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07564989 |
85 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07017305 |
86 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.05519153 |
87 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04620023 |
88 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.03770872 |
89 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.03760999 |
90 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03131494 |
91 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00051318 |
92 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.99911607 |
93 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.99337820 |
94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99175784 |
95 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99029083 |
96 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98571350 |
97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97717920 |
98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97525269 |
99 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97270500 |
100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94918992 |
101 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94446508 |
102 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.93831461 |
103 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93604860 |
104 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92599070 |
105 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92127372 |
106 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91916214 |
107 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.89453920 |
108 | P300_27268052_Chip-Seq_Bcells_Human | 0.87785075 |
109 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.87436099 |
110 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86344750 |
111 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.85519325 |
112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85287312 |
113 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.85255896 |
114 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.83922960 |
115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83236579 |
116 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82843709 |
117 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.82634222 |
118 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.82337846 |
119 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.81557809 |
120 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80583162 |
121 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80184721 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 4.06047176 |
2 | MP0005671_abnormal_response_to | 3.56504547 |
3 | MP0002396_abnormal_hematopoietic_system | 3.42491361 |
4 | MP0001835_abnormal_antigen_presentation | 3.20056858 |
5 | MP0000685_abnormal_immune_system | 3.08959556 |
6 | MP0001800_abnormal_humoral_immune | 2.88115133 |
7 | MP0002398_abnormal_bone_marrow | 2.77799925 |
8 | MP0002420_abnormal_adaptive_immunity | 2.60534614 |
9 | MP0003436_decreased_susceptibility_to | 2.57721153 |
10 | MP0001819_abnormal_immune_cell | 2.56785333 |
11 | MP0004808_abnormal_hematopoietic_stem | 2.54459529 |
12 | MP0001790_abnormal_immune_system | 2.52529506 |
13 | MP0005387_immune_system_phenotype | 2.52529506 |
14 | MP0005000_abnormal_immune_tolerance | 2.51873106 |
15 | MP0002723_abnormal_immune_serum | 2.50628545 |
16 | MP0002166_altered_tumor_susceptibility | 2.47926163 |
17 | MP0009785_altered_susceptibility_to | 2.45115735 |
18 | MP0002452_abnormal_antigen_presenting | 2.43688303 |
19 | MP0009333_abnormal_splenocyte_physiolog | 2.43131927 |
20 | MP0003303_peritoneal_inflammation | 2.43058372 |
21 | MP0001873_stomach_inflammation | 2.40827698 |
22 | MP0000703_abnormal_thymus_morphology | 2.37236626 |
23 | MP0003300_gastrointestinal_ulcer | 2.36890409 |
24 | * MP0005025_abnormal_response_to | 2.33610451 |
25 | MP0000716_abnormal_immune_system | 2.32066870 |
26 | MP0005464_abnormal_platelet_physiology | 2.31321780 |
27 | MP0002722_abnormal_immune_system | 2.29336864 |
28 | MP0002405_respiratory_system_inflammati | 2.23438137 |
29 | MP0000689_abnormal_spleen_morphology | 2.22292255 |
30 | MP0003866_abnormal_defecation | 2.10639374 |
31 | MP0002006_tumorigenesis | 2.10145795 |
32 | MP0010155_abnormal_intestine_physiology | 2.07817396 |
33 | MP0000465_gastrointestinal_hemorrhage | 2.04285857 |
34 | MP0002429_abnormal_blood_cell | 2.02501822 |
35 | MP0002419_abnormal_innate_immunity | 1.99515072 |
36 | MP0005397_hematopoietic_system_phenotyp | 1.98257083 |
37 | MP0001545_abnormal_hematopoietic_system | 1.98257083 |
38 | MP0008057_abnormal_DNA_replication | 1.92013590 |
39 | MP0000490_abnormal_crypts_of | 1.82903133 |
40 | MP0006082_CNS_inflammation | 1.82177360 |
41 | MP0010094_abnormal_chromosome_stability | 1.78353592 |
42 | MP0002148_abnormal_hypersensitivity_rea | 1.78097161 |
43 | MP0003724_increased_susceptibility_to | 1.77939161 |
44 | MP0009278_abnormal_bone_marrow | 1.69847195 |
45 | MP0003693_abnormal_embryo_hatching | 1.69431924 |
46 | MP0004947_skin_inflammation | 1.61146156 |
47 | MP0001845_abnormal_inflammatory_respons | 1.61130374 |
48 | MP0001853_heart_inflammation | 1.60949140 |
49 | MP0003077_abnormal_cell_cycle | 1.52945281 |
50 | MP0005174_abnormal_tail_pigmentation | 1.52631912 |
51 | MP0000858_altered_metastatic_potential | 1.46339473 |
52 | MP0010352_gastrointestinal_tract_polyps | 1.44622591 |
53 | MP0003111_abnormal_nucleus_morphology | 1.43731366 |
54 | MP0002933_joint_inflammation | 1.36589190 |
55 | * MP0002019_abnormal_tumor_incidence | 1.30102280 |
56 | MP0004957_abnormal_blastocyst_morpholog | 1.28918867 |
57 | MP0010307_abnormal_tumor_latency | 1.25165112 |
58 | MP0005075_abnormal_melanosome_morpholog | 1.23817573 |
59 | MP0005310_abnormal_salivary_gland | 1.22585079 |
60 | MP0003448_altered_tumor_morphology | 1.21352120 |
61 | MP0005451_abnormal_body_composition | 1.20269321 |
62 | MP0004510_myositis | 1.15263264 |
63 | MP0008469_abnormal_protein_level | 1.08338235 |
64 | MP0001533_abnormal_skeleton_physiology | 1.06919608 |
65 | MP0008007_abnormal_cellular_replicative | 1.00675335 |
66 | MP0005645_abnormal_hypothalamus_physiol | 0.99180076 |
67 | MP0001851_eye_inflammation | 0.99117843 |
68 | MP0008058_abnormal_DNA_repair | 0.98375289 |
69 | MP0002132_abnormal_respiratory_system | 0.97211468 |
70 | MP0005076_abnormal_cell_differentiation | 0.96159661 |
71 | MP0004147_increased_porphyrin_level | 0.94925928 |
72 | MP0002138_abnormal_hepatobiliary_system | 0.91776256 |
73 | MP0002009_preneoplasia | 0.88324152 |
74 | MP0000313_abnormal_cell_death | 0.86472422 |
75 | MP0002095_abnormal_skin_pigmentation | 0.86363651 |
76 | MP0000350_abnormal_cell_proliferation | 0.82091424 |
77 | MP0006054_spinal_hemorrhage | 0.81336815 |
78 | MP0002877_abnormal_melanocyte_morpholog | 0.78556521 |
79 | MP0001663_abnormal_digestive_system | 0.77378208 |
80 | MP0008961_abnormal_basal_metabolism | 0.71825197 |
81 | MP0003172_abnormal_lysosome_physiology | 0.71200760 |
82 | MP0000569_abnormal_digit_pigmentation | 0.71030890 |
83 | MP0005023_abnormal_wound_healing | 0.69365887 |
84 | MP0008995_early_reproductive_senescence | 0.67306542 |
85 | MP0000477_abnormal_intestine_morphology | 0.67282608 |
86 | MP0008260_abnormal_autophagy | 0.66926245 |
87 | MP0009763_increased_sensitivity_to | 0.66625621 |
88 | MP0000015_abnormal_ear_pigmentation | 0.66496749 |
89 | MP0005058_abnormal_lysosome_morphology | 0.65946958 |
90 | MP0009115_abnormal_fat_cell | 0.65391055 |
91 | MP0001730_embryonic_growth_arrest | 0.65114407 |
92 | MP0003566_abnormal_cell_adhesion | 0.63568370 |
93 | MP0002998_abnormal_bone_remodeling | 0.63469923 |
94 | MP0003183_abnormal_peptide_metabolism | 0.62797544 |
95 | MP0003943_abnormal_hepatobiliary_system | 0.61614913 |
96 | MP0008873_increased_physiological_sensi | 0.60870073 |
97 | MP0000343_altered_response_to | 0.60436320 |
98 | MP0003191_abnormal_cellular_cholesterol | 0.59456553 |
99 | MP0002693_abnormal_pancreas_physiology | 0.59329527 |
100 | MP0003656_abnormal_erythrocyte_physiolo | 0.59275755 |
101 | MP0003045_fibrosis | 0.59028538 |
102 | MP0002086_abnormal_extraembryonic_tissu | 0.58291225 |
103 | MP0004381_abnormal_hair_follicle | 0.57221026 |
104 | MP0001986_abnormal_taste_sensitivity | 0.56407919 |
105 | MP0000609_abnormal_liver_physiology | 0.55934168 |
106 | MP0003806_abnormal_nucleotide_metabolis | 0.55478036 |
107 | MP0004130_abnormal_muscle_cell | 0.55059451 |
108 | MP0009765_abnormal_xenobiotic_induced | 0.54220742 |
109 | MP0000371_diluted_coat_color | 0.53980615 |
110 | MP0005647_abnormal_sex_gland | 0.53846427 |
111 | MP0006036_abnormal_mitochondrial_physio | 0.53638849 |
112 | MP0004883_abnormal_blood_vessel | 0.52732626 |
113 | MP0000372_irregular_coat_pigmentation | 0.52230092 |
114 | MP0003795_abnormal_bone_structure | 0.52014126 |
115 | MP0002080_prenatal_lethality | 0.51997859 |
116 | MP0008877_abnormal_DNA_methylation | 0.51237961 |
117 | MP0005083_abnormal_biliary_tract | 0.49594262 |
118 | MP0009764_decreased_sensitivity_to | 0.49070911 |
119 | MP0003786_premature_aging | 0.48213386 |
120 | MP0005621_abnormal_cell_physiology | 0.47875142 |
121 | MP0003828_pulmonary_edema | 0.46088671 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IgM deficiency (HP:0002850) | 4.90151495 |
2 | T lymphocytopenia (HP:0005403) | 4.89519346 |
3 | Abnormality of T cell number (HP:0011839) | 4.62905555 |
4 | Chronic otitis media (HP:0000389) | 4.36001276 |
5 | Recurrent viral infections (HP:0004429) | 4.34301637 |
6 | Recurrent fungal infections (HP:0002841) | 4.31201247 |
7 | Myositis (HP:0100614) | 4.27581171 |
8 | Abnormality of T cells (HP:0002843) | 4.24708922 |
9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.14751759 |
10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.09022164 |
11 | Thrombocytosis (HP:0001894) | 4.05956354 |
12 | Panhypogammaglobulinemia (HP:0003139) | 4.05638402 |
13 | Nasal polyposis (HP:0100582) | 3.96014025 |
14 | Recurrent bronchitis (HP:0002837) | 3.93870463 |
15 | Eczematoid dermatitis (HP:0000976) | 3.85982795 |
16 | Abnormality of T cell physiology (HP:0011840) | 3.57694173 |
17 | Prolonged bleeding time (HP:0003010) | 3.54980794 |
18 | Abnormality of the fingertips (HP:0001211) | 3.51642160 |
19 | B lymphocytopenia (HP:0010976) | 3.51221404 |
20 | Abnormality of B cell number (HP:0010975) | 3.51221404 |
21 | Meningitis (HP:0001287) | 3.42686111 |
22 | Recurrent abscess formation (HP:0002722) | 3.41662950 |
23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.39644397 |
24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.39644397 |
25 | Abnormality of the nasal mucosa (HP:0000433) | 3.37246508 |
26 | Petechiae (HP:0000967) | 3.32205800 |
27 | Severe combined immunodeficiency (HP:0004430) | 3.25696489 |
28 | Retrobulbar optic neuritis (HP:0100654) | 3.17204897 |
29 | Optic neuritis (HP:0100653) | 3.17204897 |
30 | Combined immunodeficiency (HP:0005387) | 3.07926742 |
31 | Spontaneous hematomas (HP:0007420) | 3.07379217 |
32 | IgG deficiency (HP:0004315) | 3.06504206 |
33 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.04919485 |
34 | Stomatitis (HP:0010280) | 3.02730480 |
35 | Gastrointestinal inflammation (HP:0004386) | 3.02538978 |
36 | Inflammation of the large intestine (HP:0002037) | 3.01649024 |
37 | Pustule (HP:0200039) | 3.01183575 |
38 | Orchitis (HP:0100796) | 2.98285530 |
39 | Recurrent bacterial skin infections (HP:0005406) | 2.95627418 |
40 | Acute lymphatic leukemia (HP:0006721) | 2.95465132 |
41 | Abnormal platelet volume (HP:0011876) | 2.93542043 |
42 | Encephalitis (HP:0002383) | 2.90541363 |
43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.87293356 |
44 | Obstructive lung disease (HP:0006536) | 2.87293356 |
45 | Epistaxis (HP:0000421) | 2.85518303 |
46 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.84306763 |
47 | Vasculitis (HP:0002633) | 2.81275174 |
48 | Lymphopenia (HP:0001888) | 2.80188280 |
49 | Eosinophilia (HP:0001880) | 2.78841786 |
50 | Cellulitis (HP:0100658) | 2.78738041 |
51 | Abnormal number of erythroid precursors (HP:0012131) | 2.77313247 |
52 | Increased IgE level (HP:0003212) | 2.74513571 |
53 | Abnormality of eosinophils (HP:0001879) | 2.73858874 |
54 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.73591212 |
55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.70606902 |
56 | Increased density of long bones (HP:0006392) | 2.70458950 |
57 | Leukocytosis (HP:0001974) | 2.70451396 |
58 | Reticulocytopenia (HP:0001896) | 2.70024050 |
59 | Impaired platelet aggregation (HP:0003540) | 2.69338217 |
60 | Abnormal platelet function (HP:0011869) | 2.69338217 |
61 | Thyroiditis (HP:0100646) | 2.68013542 |
62 | Recurrent skin infections (HP:0001581) | 2.67968795 |
63 | Granulocytopenia (HP:0001913) | 2.64936841 |
64 | Gastrointestinal stroma tumor (HP:0100723) | 2.64018854 |
65 | Chest pain (HP:0100749) | 2.63770140 |
66 | Lymphoma (HP:0002665) | 2.63327642 |
67 | Hemoptysis (HP:0002105) | 2.62717853 |
68 | Arterial thrombosis (HP:0004420) | 2.58765544 |
69 | Mediastinal lymphadenopathy (HP:0100721) | 2.56811356 |
70 | IgA deficiency (HP:0002720) | 2.56602051 |
71 | Urticaria (HP:0001025) | 2.56230701 |
72 | Viral hepatitis (HP:0006562) | 2.54840970 |
73 | Acute myeloid leukemia (HP:0004808) | 2.53471655 |
74 | Verrucae (HP:0200043) | 2.51695405 |
75 | Papilloma (HP:0012740) | 2.51695405 |
76 | Osteomyelitis (HP:0002754) | 2.47482464 |
77 | Increased IgM level (HP:0003496) | 2.46668554 |
78 | Agammaglobulinemia (HP:0004432) | 2.45166456 |
79 | Gingival bleeding (HP:0000225) | 2.43264397 |
80 | Basal cell carcinoma (HP:0002671) | 2.38205270 |
81 | Pulmonary infiltrates (HP:0002113) | 2.36943359 |
82 | Keratoconjunctivitis sicca (HP:0001097) | 2.34546012 |
83 | Autoimmune hemolytic anemia (HP:0001890) | 2.33904308 |
84 | Abnormality of the prostate (HP:0008775) | 2.33512745 |
85 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.33173004 |
86 | Increased mean platelet volume (HP:0011877) | 2.31064416 |
87 | Chronic diarrhea (HP:0002028) | 2.30769175 |
88 | Autoimmune thrombocytopenia (HP:0001973) | 2.30560402 |
89 | Hypertensive crisis (HP:0100735) | 2.26952370 |
90 | Poikiloderma (HP:0001029) | 2.25087824 |
91 | Amaurosis fugax (HP:0100576) | 2.22475035 |
92 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.19744261 |
93 | Periodontitis (HP:0000704) | 2.17084786 |
94 | Myelodysplasia (HP:0002863) | 2.16832481 |
95 | Gastrointestinal infarctions (HP:0005244) | 2.16201274 |
96 | Joint swelling (HP:0001386) | 2.15712235 |
97 | Skin rash (HP:0000988) | 2.15135556 |
98 | Bronchitis (HP:0012387) | 2.13403296 |
99 | Keratoconjunctivitis (HP:0001096) | 2.11409429 |
100 | Microcytic anemia (HP:0001935) | 2.09821593 |
101 | Colitis (HP:0002583) | 2.09632405 |
102 | Vacuolated lymphocytes (HP:0001922) | 2.07657039 |
103 | Increased cerebral lipofuscin (HP:0011813) | 2.06210448 |
104 | Hypoplasia of the thymus (HP:0000778) | 2.05797305 |
105 | Sepsis (HP:0100806) | 2.05310666 |
106 | Pulmonary embolism (HP:0002204) | 2.05149533 |
107 | Chronic sinusitis (HP:0011109) | 2.04660460 |
108 | Hypochromic microcytic anemia (HP:0004840) | 2.03615922 |
109 | Pallor (HP:0000980) | 2.02935917 |
110 | Aplastic anemia (HP:0001915) | 2.01868158 |
111 | Abnormality of macrophages (HP:0004311) | 2.00758337 |
112 | Gingivitis (HP:0000230) | 2.00636217 |
113 | Prominent nose (HP:0000448) | 1.99700134 |
114 | Entropion (HP:0000621) | 1.98800552 |
115 | Abnormality of the pleura (HP:0002103) | 1.98761427 |
116 | Volvulus (HP:0002580) | 1.98428466 |
117 | Leukopenia (HP:0001882) | 1.94687065 |
118 | Abnormality of iron homeostasis (HP:0011031) | 1.94021125 |
119 | Recurrent sinusitis (HP:0011108) | 1.93614140 |
120 | Hypochromic anemia (HP:0001931) | 1.93382871 |
121 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93340227 |
122 | Hypergammaglobulinemia (HP:0010702) | 1.91895001 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 5.12576597 |
2 | RIPK4 | 4.51797842 |
3 | TXK | 4.09502112 |
4 | EEF2K | 3.91936796 |
5 | PRPF4B | 3.10587251 |
6 | JAK3 | 2.96308002 |
7 | ZAP70 | 2.49320774 |
8 | ITK | 2.40600369 |
9 | STK10 | 2.37328032 |
10 | GRK6 | 2.10696356 |
11 | TEC | 2.05521720 |
12 | TYK2 | 2.05332020 |
13 | BTK | 2.02786713 |
14 | PKN2 | 1.78179550 |
15 | KIT | 1.73197152 |
16 | MAP3K10 | 1.70424097 |
17 | SYK | 1.58348297 |
18 | IKBKE | 1.57932181 |
19 | FGFR4 | 1.57238191 |
20 | LCK | 1.51932219 |
21 | TRIB3 | 1.50510755 |
22 | TAOK3 | 1.49170955 |
23 | FGFR3 | 1.49017456 |
24 | CDC7 | 1.48923489 |
25 | NME2 | 1.47665726 |
26 | LRRK2 | 1.45669397 |
27 | CDK12 | 1.45535119 |
28 | IRAK4 | 1.39945975 |
29 | JAK1 | 1.37529272 |
30 | FES | 1.35769301 |
31 | PIM1 | 1.34172992 |
32 | MAP2K3 | 1.32829548 |
33 | MAP3K14 | 1.31773195 |
34 | HCK | 1.30220574 |
35 | SMG1 | 1.28685010 |
36 | RPS6KB2 | 1.25719373 |
37 | NEK2 | 1.21570201 |
38 | TBK1 | 1.19860287 |
39 | CDK4 | 1.17369835 |
40 | BLK | 1.16975811 |
41 | CLK1 | 1.16689163 |
42 | CSK | 1.16371611 |
43 | RPS6KA4 | 1.12339506 |
44 | PIK3CG | 1.09725083 |
45 | TNK2 | 1.08061619 |
46 | TLK1 | 1.06405397 |
47 | SIK2 | 1.06355574 |
48 | BMPR2 | 1.05765895 |
49 | CSF1R | 1.05392999 |
50 | PASK | 1.02150066 |
51 | NLK | 1.01698726 |
52 | TESK2 | 0.96731884 |
53 | EPHB1 | 0.96141756 |
54 | TGFBR1 | 0.95748610 |
55 | MATK | 0.95204996 |
56 | ALK | 0.93745525 |
57 | TSSK6 | 0.92502459 |
58 | FLT3 | 0.92460828 |
59 | IKBKB | 0.91535497 |
60 | STK4 | 0.91165585 |
61 | TRPM7 | 0.86370162 |
62 | LYN | 0.85206822 |
63 | JAK2 | 0.85068278 |
64 | MAPK12 | 0.81911960 |
65 | MARK3 | 0.78711855 |
66 | ATR | 0.78695369 |
67 | KDR | 0.75083648 |
68 | CDK6 | 0.72022436 |
69 | MAP3K1 | 0.71953510 |
70 | FRK | 0.70719634 |
71 | MAP3K7 | 0.69617019 |
72 | BRD4 | 0.69342909 |
73 | HIPK2 | 0.69211804 |
74 | MAP3K8 | 0.66827088 |
75 | TAOK1 | 0.65611994 |
76 | VRK1 | 0.65600661 |
77 | STK24 | 0.64189869 |
78 | CHUK | 0.62979028 |
79 | TTN | 0.61851154 |
80 | MST4 | 0.61342463 |
81 | PRKCH | 0.59467074 |
82 | NEK9 | 0.58003009 |
83 | CAMKK2 | 0.56321572 |
84 | NUAK1 | 0.56108833 |
85 | RAF1 | 0.54818178 |
86 | CDK9 | 0.53856478 |
87 | ZAK | 0.53606812 |
88 | CAMKK1 | 0.51992186 |
89 | MAPK4 | 0.51693807 |
90 | PTK6 | 0.51291110 |
91 | FGR | 0.49673470 |
92 | PIM2 | 0.49216021 |
93 | RPS6KA6 | 0.48402889 |
94 | TGFBR2 | 0.47898080 |
95 | WEE1 | 0.47561740 |
96 | IRAK3 | 0.46588002 |
97 | IRAK1 | 0.46328141 |
98 | PDK1 | 0.45353084 |
99 | MARK2 | 0.45016078 |
100 | YES1 | 0.44496613 |
101 | CDK7 | 0.44115754 |
102 | MAPK7 | 0.43528553 |
103 | AURKB | 0.43422996 |
104 | ACVR1B | 0.42120644 |
105 | MAPK3 | 0.41828759 |
106 | * PRKCQ | 0.41736249 |
107 | CHEK1 | 0.40982379 |
108 | MAPK11 | 0.40211437 |
109 | RPS6KL1 | 0.39170500 |
110 | RPS6KC1 | 0.39170500 |
111 | BCKDK | 0.38580082 |
112 | MAP2K6 | 0.37598221 |
113 | SIK3 | 0.37136856 |
114 | CCNB1 | 0.36639763 |
115 | MELK | 0.36626965 |
116 | MAPKAPK2 | 0.36423334 |
117 | MKNK1 | 0.35733682 |
118 | ERN1 | 0.35163456 |
119 | MAP2K2 | 0.34765646 |
120 | TAOK2 | 0.34581067 |
121 | MAP3K13 | 0.34026349 |
122 | CDC42BPA | 0.33699352 |
123 | PDPK1 | 0.33107991 |
124 | RPS6KA5 | 0.32701737 |
125 | KSR2 | 0.32431796 |
126 | MAPKAPK3 | 0.31937078 |
127 | MAP3K11 | 0.31325229 |
128 | ILK | 0.30599826 |
129 | DYRK3 | 0.30035664 |
130 | SRPK1 | 0.29373326 |
131 | PDGFRB | 0.29318621 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.00046478 |
2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.78105922 |
3 | DNA replication_Homo sapiens_hsa03030 | 2.61362390 |
4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.59476661 |
5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.48199905 |
6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.34790736 |
7 | Measles_Homo sapiens_hsa05162 | 2.33445957 |
8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.26758184 |
9 | Ribosome_Homo sapiens_hsa03010 | 2.19879081 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.15908452 |
11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.11430401 |
12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.02850372 |
13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.92608253 |
14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.87672038 |
15 | Allograft rejection_Homo sapiens_hsa05330 | 1.84145247 |
16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.81914466 |
17 | Mismatch repair_Homo sapiens_hsa03430 | 1.76992537 |
18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.63837089 |
19 | Base excision repair_Homo sapiens_hsa03410 | 1.60409345 |
20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60048104 |
21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.57186995 |
22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53158778 |
23 | Spliceosome_Homo sapiens_hsa03040 | 1.53066592 |
24 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.49777324 |
25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.45903633 |
26 | Asthma_Homo sapiens_hsa05310 | 1.45734872 |
27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45198638 |
28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.45126975 |
29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39550463 |
30 | Hepatitis B_Homo sapiens_hsa05161 | 1.37213173 |
31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.33254012 |
32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29695831 |
33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27979560 |
34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.26048324 |
35 | Homologous recombination_Homo sapiens_hsa03440 | 1.25015439 |
36 | Shigellosis_Homo sapiens_hsa05131 | 1.24600587 |
37 | Cell cycle_Homo sapiens_hsa04110 | 1.21715086 |
38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.20924444 |
39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18231232 |
40 | Platelet activation_Homo sapiens_hsa04611 | 1.17617136 |
41 | Apoptosis_Homo sapiens_hsa04210 | 1.14688622 |
42 | Influenza A_Homo sapiens_hsa05164 | 1.10660155 |
43 | HTLV-I infection_Homo sapiens_hsa05166 | 1.09549895 |
44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.09013522 |
45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08827676 |
46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08658019 |
47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.07653062 |
48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07285666 |
49 | Legionellosis_Homo sapiens_hsa05134 | 1.04817442 |
50 | RNA transport_Homo sapiens_hsa03013 | 1.01844310 |
51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01302375 |
52 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99133049 |
53 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.98051592 |
54 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.97694510 |
55 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.94852247 |
56 | RNA degradation_Homo sapiens_hsa03018 | 0.93687139 |
57 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.92847544 |
58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91481241 |
59 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.86584145 |
60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85324635 |
61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.84402328 |
62 | Tuberculosis_Homo sapiens_hsa05152 | 0.83355321 |
63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81642213 |
64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81479782 |
65 | Colorectal cancer_Homo sapiens_hsa05210 | 0.80958133 |
66 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.80608175 |
67 | Malaria_Homo sapiens_hsa05144 | 0.75209133 |
68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75204571 |
69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75056909 |
70 | Pertussis_Homo sapiens_hsa05133 | 0.74112275 |
71 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73379847 |
72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72690126 |
73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71434934 |
74 | Phagosome_Homo sapiens_hsa04145 | 0.67775562 |
75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67756178 |
76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67064337 |
77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66146030 |
78 | Hepatitis C_Homo sapiens_hsa05160 | 0.66115080 |
79 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.65241632 |
80 | Alcoholism_Homo sapiens_hsa05034 | 0.62997696 |
81 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.61165463 |
82 | Salmonella infection_Homo sapiens_hsa05132 | 0.61063019 |
83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57528459 |
84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57052281 |
85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56363910 |
86 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.55631029 |
87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51873185 |
88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51785266 |
89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49586094 |
90 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46857364 |
91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46362012 |
92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45644605 |
93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45520944 |
94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44634287 |
95 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44240718 |
96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42989923 |
97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42656000 |
98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42217018 |
99 | RNA polymerase_Homo sapiens_hsa03020 | 0.41905848 |
100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41590108 |
101 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.40517745 |
102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39705211 |
103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38455820 |
104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36886478 |
105 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36740354 |
106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36648941 |
107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36534125 |
108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36197542 |
109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35302501 |
110 | Lysosome_Homo sapiens_hsa04142 | 0.33069690 |
111 | Prostate cancer_Homo sapiens_hsa05215 | 0.32728820 |
112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32642506 |
113 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32263295 |
114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31278845 |
115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31109296 |
116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30950287 |
117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30694775 |
118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.29676621 |
119 | Insulin resistance_Homo sapiens_hsa04931 | 0.29397279 |
120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27020085 |
121 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.24138277 |
122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24064193 |
123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.22984124 |
124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.21589604 |
125 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.16023998 |